We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





New Yeast-Based COVID-19 Diagnostic Test Could Detect SARS-CoV-2 in Saliva Faster Than RT-PCR

By HospiMedica International staff writers
Posted on 01 Feb 2021
Print article
Image: Based on a reaction between yeast and the novel coronavirus, the test will rapidly detect the presence of SARS-CoV-2 in saliva and will be available by mid-2021 (Photo courtesy of BIOinFOOD)
Image: Based on a reaction between yeast and the novel coronavirus, the test will rapidly detect the presence of SARS-CoV-2 in saliva and will be available by mid-2021 (Photo courtesy of BIOinFOOD)
A rapid COVID-19 diagnostic test based on a reaction between yeast and the novel coronavirus, will rapidly detect the presence of SARS-CoV-2 in saliva and will be available by mid-2021.

The yeast-based COVID-19 diagnostic test being developed by BIOinFOOD (São Paulo, Brazil) uses a biosensor consisting of a genetically modified brewer's yeast (Saccharomyces cerevisiae), which changes color if human ACE2 receptor expressed by the yeast's membrane binds to the spike glycoprotein present on the external surface of the virus.

The innovation involved in the COVID-19 diagnostic test came out of a technology mastered previously by BIOinFOOD. The firm offers a biotech platform based on S. cerevisiae, a versatile microorganism widely used in industry as a biofactory. Organic acids, amino acids, enzymes, and therapeutic proteins are some of the outputs of the platform. The firm also develops custom yeasts for use by bakeries and breweries to suit consumer tastes.

According to the researchers' expectations, the new test will be both fast and cheaper than RT-PCR because of the low cost of yeast, the main input. Another important difference is that it will probably use saliva. Being non-invasive is an advantage for diagnostic tests. Many people experience intense discomfort when undergoing collection of their material by nasal swab. Additionally, the sensitivity of the test is expected to be high, meaning it will be able to detect the virus only a few days after infection. Once the working hypothesis has been fully validated, the scientists expect the test to be brought to market and freely available for purchase during first-half 2021. The raw materials for the product are simple and distribution of the diagnostic test should be logistically straightforward.

"The yeast is normally beige. When this interaction takes place, the presence of the virus is signaled by a fluorescent green that can easily be detected by the equipment typically found in clinical analysis labs," said Gleidson Silva Teixeira, one of BIOinFOOD's partners. "We plan eventually to have the yeast emit red light, which will be easier to identify. In this case, anyone will be perfectly capable of using the test, even at home."

Related Links:
BIOinFOOD

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
Transcatheter Heart Valve
SAPIEN 3 Ultra

Print article

Channels

Surgical Techniques

view channel
Image: Schematic diagram of intra-articular pressure detection using a sensory system in a sheep model (Photo courtesy of Science China Press)

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Knee replacement surgery is a widely performed procedure to relieve knee pain and restore joint function, with over one million surgeries conducted annually. However, 10%-20% of patients remain dissatisfied... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.